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DNA Minor Groove Binding of Cross-Linked Lexitropsins: Experimental
Conditions Required to Observe the Covalently Linked WPPW (Groove
Wall-Peptide-Peptide-Groove Wall) Motif
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ABSTRACT A theoretical analysis of binding interactions between covalently cross-linked lexitropsins and DNA is undertaken,
in which a novel cyclic symmetric 2:2 dimeric lexitropsin-DNA-binding model is proposed. Applicability of commonly used
techniques including NMR, quantitative footprinting, CD, and ethidium fluorometry to differentiate the covalently linked WPPW
(groove Wall-Peptide-Peptide-groove Wall) from a 2:2 cross-linked lexitropsin-DNA duplex structure is examined.
INTRODUCTION
The naturally occurring oligopeptide antibiotics netropsin 1
and distamycin 2 (Fig. 1) represent important paradigms of
sequence-selective DNA minor groove binders (Zimmer and
Wahnert, 1986). Generalized information-reading molecules
analogous to these natural products are defined as lex-
itropsins, and their DNA recognition capacity has been ex-
ploited extensively (Kopka et al., 1985; Lown, 1988, 1990,
1992, 1993). Structural elucidation of 2:1 antiparallel side-
by-side binding between distamycin and oligonucleotides
further contributes to our understanding of interactions be-
tween minor groove binders and DNA (Pelton and Wemmer,
1989, 1990, Fig. 2). This minor groove wall-peptide-peptide-
minor groove wall (WPPW) antiparallel side-by-side motif
was recently found to be extendable to interactions between
imidazole-containing lexitropsins and corresponding
matched base sequences with much higher cooperativity
(Dwyer et al., 1992; Mrksich et al., 1992). More interest-
ingly, one imidazole-containing lexitropsin molecule and
one distamycin molecule can occupy the same site, consti-
tuting a heterodimeric WPPW motif, with greater binding
strength than either of the corresponding homodimeric mo-
tifs at the same site (Geierstanger et al., 1993; Mrksich and
Dervan, 1993a). Particular interest in the latter heterodimeric
complex attaches to its unique discriminatory strand-specific
recognition of sequences containing GC base pairs. To ex-
ploit the latter property and, therefore, to provide potentially
higher sequence-specific recognition, novel covalently
linked dimeric lexitropsins were designed, synthesized,
and their DNA-binding characteristics examined (Dwyer
et al., 1993; Mrksich and Dervan, 1993b, 1994; Chen and
Lown, 1994) (Figs. 2 and 3).
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In one study of polymethylene-linked bis-oligopeptides
3a-3d (Fig. 3), it was concluded that the linker length has
little effect on the binding mode and binding strength of these
dimeric ligands (Dwyer et al., 1993; Mrksich and Dervan,
1993b). From the NMR studies, it was indicated that all four
dimeric lexitropsins bind with nearly identical geometry to
the oligonucleotide-possessing 5'-TGACT-3' core in a uni-
formWPPW 1:1 bidentate mode. Structures of the covalently
unconnected WPPW motif and the covalently connected
WPPW motif were suggested to be nearly identical in the
5'-TGACT-3' site (Dwyer et al., 1993). From the quantita-
tive DNase I footprinting experiments, binding constants for
lexitropsin dimers 3a-3d showed little difference (Mrksich
and Dervan, 1993). There is an apparent consistency between
NMR spectroscopy and quantitative footprinting results.
For a similar series of structures 4a-4d (Fig. 3), we con-
cluded: the tetrakis(methylene) chain linker is too short to
allow any bidentate binding of dimer 4a to the alternatingAT
polymer and certainly the tris(methylene) chain linker is far
too short by extrapolation; the pentakis(methylene) and
hexakis(methylene) linkers permit dominance of the WPPW
1:1 bidentate binding of dimers 4b and 4c but with major
local structural distortions; the heptakis(methylene) is a
much better linker to facilitate the bidentate binding of 4d but
is still far from ideal; the linker length clearly has a profound
effect on the binding mode and binding strength (Chen and
Lown, 1994). This conclusion is based on interpretation of
CD titration curves and ethidium fluorometry experiments
with homo- and alternating AT polymers, by applying the
McGhee-von Hippel equation. There is a strict correspon-
dence among CD, ethidium fluorescence quenching, and
ethidium displacement data. Despite substantial differences
in terms of lexitropsin-DNA duplex-interacting systems and
the experimental methods used to establish the binding char-
acteristics in these two independent studies, we believe that
it is worth searching for reasons other than these apparent
differences, because the effect of linker length has to be un-
derstood to further the design of cross-linked or bridged lex-
itropsins. Moreover, these novel and unprecedented dimeric
lexitropsin structures and their interactions with DNA oli-
gomers and polymers require wide ranging examination
2041
Volume 68 May 1995
H2N H
cr _ H H, 1NHj2
H2N IIcr
/ 0 N 0
H
H N H NH2~
I H N
10N
0
2
FIGURE 1 DNA minor groove-binding oligopeptides netropsin and dis-
tamycin.
using an array of physical techniques in case unanticipated
modes of binding are encountered, and possible limitations
of various techniques have to be appreciated to derive mean-
ingful conclusions. The present report summarizes our theo-
retical exploration to resolve disagreements between two in-
dependent studies, by analyzing the various binding
phenomena these ligands may exhibit under different con-
ditions and, particularly, to delineate the utility and limita-
tions of different analytical techniques that have been used.
EFFECT OF CROSS-LINKAGE ON
BINDING EQUILIBRIUM
Let us start with a dimeric lexitropsin and an oligonucleotide
capable of accommodating a WPPW motif. First of all, it
must be recognized that a dimeric ligand with a flexible
linker may bind to two DNA duplexes simultaneously, in
addition to the desired 1:1 bidentate binding, as illustrated in
Fig. 2. From model inspection, cross-linked lexitropsin
dimers with linkers longer than a bis(methylene) chain can
avoid serious steric clash between two bound duplexes.
Therefore, the formation of polymeric aggregation in the so-
lution of the DNA and the dimeric ligand has to be taken into
account. This aggregation factor should be more significant
NH N-
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FIGURE 3 Design of cross-linked lexitropsins.
under NMR titration conditions where the DNA concentra-
tion is relatively high. Second, structural differences between
the 1:1 bidentate WPPW motif and those WPPW motifs in
symmetric cyclic n:n complexes (e.g., 2:2, 3:3, Fig. 4) cannot
be readily differentiated from standard one-dimensional and
two-dimensional NMR (e.g., NOESY) spectra. Similar sets
of signals are expected for all of these motifs. Therefore, the
observation of a single DNA-ligand complex with a stoi-
chiometric ratio of 1:1 is not sufficient in itself to prove
which structure is really present in solution. For these two
reasons, symmetric higher polymeric complexes have to be
considered as alternative possibilities.
With these considerations in mind, we may gain better
insight by analyzing the binding equilibrium that includes a
putative 2:2 symmetric complex, as illustrated in Fig. 5.
The binding isotherm equation is as follows:
Kll[L] + 2K11K21[L]2 + K11K,2[L][D] + 2K1jK21K22A[L][D]
y = 22
= 1 + Kll[L] + K11K2j[L]2 + 2K11K12L][D] + 2K,1K21K22A[L] [D]
,y is the binding density, the number of bound ligands per
oligonucleotide. [D] and [L] are concentrations of free DNA
and the bidentate ligand. Kll, K21, K12, K22A, and K22B are
compositebindingconstants:K11 = [DL]I[D][L],K2, = [DL2]/-
[DL][L], K12 = [D2L]/[DL][D], K22A = [D2L2]/[DL2][D], K22B
= [D2L2]/[D2L][L]- [DL] and [D2L2] are total concentrations
of DL and D2L2 species, respectively. Pathway A
(DL->DL2->D2L2) and pathway B (DL--DL2-D2L2) have
the same start and end points. Therefore, K21K22A = K12K22B.
a = [DL]closed/[DL]open, which characterizes the tendency to
form the closed bidentate complex versus the open mono-
dentate complex or the 1:1 bidentate-binding enhance-
ment over the 1:1 monodentate binding. Similarly, 13 =
3' 5' 3' 5'
FIGURE 2 The 2:1 WPPW binding
motif and the desired bidentate binding
of a cross-linked lexitropsin (only
hydrogen-bonding interactions are
shown).
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FIGURE 4 Possible structures of 1:1 stoichiometric ratio.
[D2L2] closed/[D2L2]open9 which expresses the tendency to
form the closed 2:2 complex versus the open 2:2 complex
or the 1:1 bidentate-binding enhancement of the "biden-
tate ligand" DL2 over the 1:1 monodentate binding. It is
noted here that all concentrations are in M.
We may define k1l = [DL]open/[D][L], k21 = [DL2]/[DL]open
X [L], k12 = [D2L]/[DL]open X [D] and k22a = [D2L2]open/
[DL2] X [D]. As a result, K1l = (1 + a)k1j, K21 = k21/(1 +
a), K12 = k,2/(1 + a) and K22A = (1 + 13)k22a. 2KllK2,[L]2
and KjK142[L][D] terms in the numerator of the binding iso-
therm equation, representing contributions from DL2 and D2L
species, respectively, are equal to 2k1lk2l[L]2 and k1lkl2[L]-
[D]. If nonbinding appendages of bidentate ligands do not
influence 1:1 WPW and 2:1 WPPW motifs significantly,
which is supported by our previous binding constant mea-
surements (Chen and Lown, 1994), k1l and k21l will be more
or less unchanged in comparison with those of the monomer,
and k1l, k12, and k22a will be approximately equal. Therefore,
the DL2 species as well as the D2L species have more or less
constant coefficients for their corresponding terms, among
all dimeric lexitropsins. The same situation applies to the
open DL species as well as the open D2L2 species. Logically,
the interesting species to investigate will be the closed 1:1
bidentate DL complex and the closed symmetric 2:2 D2L2
complex, both having changeable coefficients (due to
changeable a and 3) for their corresponding terms among all
dimeric ligands. More importantly, cases of interest to us
have either the bidentate 1:1 complex or the symmetric 2:2
complex assume dominance (i.e., a >> 1 or (3 >> 1), thus
contributing to difficulties of differentiation, for example, by
NMR spectroscopy. Correspondingly, the DL2, D2L, the
monodentate-binding DL, and the open D2L2 contributions
should be negligible in such cases.
If the bidentate-binding DL predominates under the ex-
perimental conditions, the following relationship holds:
[DL]closed >> [D2L2]closed or [DL] >> [D2L2] closed.
Therefore, (1 + a)kl[L] > 2KllK21(3k220)[L]2[D] =
2f3kllk2lk22a[L]2[D],
or
[D][L] < (1 + a)/2f3k2lk22a. (1)
When the added ligand is 1/N times the total DNA con-
centration (i.e., [L]total = [D]total/N, [DL] [L]Iotal =[D]totaI/Nf
because very little free ligand exists in the solution during
titration because of the large binding constants generally ob-
served (over 106 M-1). Because [D]total [D] + [DL], N X[DL] = [D] + [DL] or [DL]/[D] = 1/(N - 1).
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FIGURE A binding model including a symmetric 2:2 complex. D rep-
resents the DNA with a binding site; L is a symmetric dimeric lexitropsin.
Because K11 = (1 + ae)k11 = [DL]/[D][L], [L] = 1/
(N - 1) X (1 + at)k11).
Substitution of this expression into Eq. 1 leads to to the
following inequality:
[D] < (N -1) >X (1 + at)2k11/2(3k21k22.
Also,
[Dttl[D]
Therefore,
Nx (1 + )k[D]total < 2(3k21 k2k5212l22a (2)
Equation 2 is approximately the condition to be satisfied
if the closed bidentate DL complex is dominant.
In contrast, if the symmetric tetraplex D2L2 is predominant,
(1) will be reversed:
[D][L > (1 + a)/2f3k2lk22a. (3)
When [L]50551 = [D]50551/N, 2[D2L2]ClOSed 2[D2L2]
[L]total = [D]total/N. Because [D]total [D] + 2[DA]closedl
2N X [D2L2]Clmd [D] + 2[D2A]cosed or [D2L2]cjOsd [D]/2(N- 1).
Because K11K2, X (13k22a) = kj1k21 X (f3k22a) =
[D2L2]closed/[D]2[L]2 = 1/(2(N - 1) X [D] [L]2), [L] = (2(N - 1) X [D]kjjk213k22a)
Substitution of the latter expression into Eq. 3 leads to the
following inequality:
([D]/2(N - 1) X kl1k2l 13k22a)05 > (1 + a)/2f3k2l k22a,
i.e.
[D] > (N - 1) X (1 + a)2k11/2p3k2lk22a-
[Dtotal I[D] + 2[D2L2] = (1 + 1/(N - 1)) [D].
i.e.
Dltota NX (1 + a)2k11
D 21k22a
Equation 4 specifies the required condition to allow the
symmetric 2:2 complex to prevail. Equations 2 and 4 are
different only in the direction of the inequality symbol. They
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are merged to give Eq. 5:
N X (1 + a)2ki
=Z (5)
2pk2l k22a
In other words, the relative magnitude of Z and the total
DNA concentration decides whether 1:1 or 2:2 complexes
will predominate. If [D]total > Z, the 2:2 symmetric complex
is predominant and, in contrast, the 1:1 bidentate complex
prevails when [D]tOtM < Z.
Equation 5 has some important physical implications.
First, for a given bidentate ligand, the experimental condi-
tions (e.g., [D]toal) have a significant role to play in shifting
the DL and D2L2 equilibrium, and sensitive techniques fa-
cilitate the observation of the 1:1 bidentate complex. Second,
the binding constant k,c is more directly relevant to the bind-
ing equilibrium because kll and k22a are similar to each other
from the early analysis and cancel each other. Moreover,
under the same conditions, bidentate ligands ofvarious linker
length will behave differently in terms of the position of
equilibrium, depending on the significance of the bidentate
binding (a) and the ease of formation of the symmetric 2:2
complex (f). Finally, the order of a is 2, whereas the order
of ,B is 1 in Eq. 5, which is a direct manifestation of different
stoichiometries of the bidentate DL and symmetric 2:2 com-
plexes. Clearly, the stoichiometry factor will always favor
the formation of the 1:1 bidentate complex over the 2:2 com-
plex, even for cases with a < 1.
To assess further the binding equilibrium under various
conditions using Eq. 5, we need to know theoretical limits of
a and 3 values. When two monomeric ligands of a "mac-
romolecule" are covalently linked to provide a dimeric li-
gand, its bidentate-binding constant ideally equals 55.6 times
the product of two individual monomeric binding constants,
provided that there is neither net enthalpy change nor other
entropy gain or loss except the mixing entropy gain due to
differential stoichiometry of binding equilibria between the
monomeric ligands-macromolecule system and the dimeric
ligand-macromlecule system (LePecq and Roques, 1986;
Chipman and Sharon, 1969). Specifically, the ideal condition
means: 1) there is no interaction between two monomeric
moieties in the dimeric ligand in solution; 2) there is no
conformational enthalpy and entropy gain or loss from the
covalent linkage during binding of the dimeric ligand, the
covalent linkage does not interact with the macromolecule,
and it does not make the monodentate binding of the dimeric
ligand significantly different from the binding of monomers
structurally and energetically; 3) structures of the dimeric
ligand-macromolecule binary complex and monomeric
ligands-macromolecule ternary complex are essentially the
same except the former has a linker; and 4) there is no ad-
ditional translational, rotational, and vibrational entropy gain
or loss in the step from the monodentate binary complex to
the bidentate binary complex, in comparison with the cor-
responding step from the 1:1 monomer-"macromolecule"
complex to the 2:2 complex (Page and Jencks, 1971). The
relationship between the ideal bidentate-binding constant
and two monomeric binding constants appears to serve well
as a reference point to assess the covalent linkage effect
(LePecq and Roques, 1986; Chipman and Sharon, 1969).
Here it is noted that the hypothetical 1 M standard state for
solutes has to be adopted for this relationship to be valid. If
the hypothetical mole fraction unity state is adopted instead,
the coefficient has to change from 55.6 into 1 (Chipman and
Sharon, 1969).
Therefore, the dimeric lexitropsin ligand L in Fig. 5 has an
ideal bidentate-binding constant k11 = [DL]c1OJ[D][L] =
ak1l = 55.6 kI X k2, under the ideal condition just stated.
Here kI and k2 are stepwise binding constants of the mono-
meric ligand molecule when bound to the oligonucleotide to
form a 2:1 WPPW motif. a = 55.6 kI X k2/kll 55.6 k2
because k1 kll. If we take the intermediate DL2 as a bi-
dentate ligand of the oligonucleotide, its ideal bidentate-
binding constant k22a = [D2L2]c1OJ[DL2][D] = 3k22a = 55.6
kI X k2. 3 = 55.6 k, X k2/k22a 55.6 k2, because kIc k22a.
When N = 2, which is the halfway point in a titration
experiment,
N X a2k11 _ a2k
2=k2j3k22a Ik2ik22a (6)
If both a and ( are optimized to the ideal value 55.6 k2,
Z = 55.6 k2 kll / k2lk22a. Z 55. 6 M, because k2 Ik2l and
kIlc k22a. According to Eq. 5, the total concentration of the
oligonucleotide has to achieve a physically impossible high
value of55.6M to have the symmetric D2L2 dominant. There-
fore, under normal conditions, the bidentate DL 1:1 complex
will predominate. This shows that the symmetric D2L2 tet-
raplex cannot compete with the covalently connectedWPPW
motif when both motifs can be formed in the ideal binding
affinity. It follows naturally that the tetraplex will compete
even less well, if the binding affinity is not optimized to the
ideal value for the tetraplex but the covalently connected 1:1
WPPW motif.
Ifwe assume that , is optimized to the ideal value of 55.6
k2, a perfectly maximized value, the critical a value, which
decides whether a 1:1 bidentate or a 2:2 symmetric complex
is going to be predominant, can be obtained from the fol-
lowing procedure. From Eq. 6, Z = a2kl1/(3k2lk22a = a2kill/
55.6k2k2lk22a a2/55.6(k2)2. Substitute this into Eq. 5 and
rearrange the equation to give:
a Vs k2X (55.6[DNA]total )0s5. (7)
In a typical NMR titration, [DNA]tot1 1 mM. Therefore,
Eq. 7 can be then converted into: a Vs 0.23 k2. That is to say,
if the bidentate-binding enhancement a factor exceeds 0.23
k2, which is only 0.41% of the ideal value 55.6 k2, the bi-
dentate binding is going to remain dominant. Therefore,
some considerable strain or entropy loss can be accommo-
dated without compromising the binding mode.
However, because the value of k2 is in general rather large,
the critical value 0.23 k2 is not something easily achieved
experimentally. For example, k2 in our dimeric distamycin
cases is -20 X 106 M-1 (Chen and Lown, 1994) (the k2
constant for imidazole- and pyridine-containing lexitropsins
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with the corresponding matched oligonucleotide is likely
higher than this value because of the high cooperativity gen-
erally observed), and the critical value is calculated to be 4.7
X 106. The bidentate-binding enhancement of this magnitude
has not been accomplished experimentally yet (Mrksich and
Dervan, 1993b, 1994; Chen and Lown, 1994) (our unpub-
lished data). In short, if the bidentate-binding enhancement
does not reach a still rather large value, the symmetric D2L2
is going to become dominant. Larger k2 values will make the
dominance more complete. This conclusion is based on the
formation of an ideally optimized symmetric tetraplex. Let
us assume that a is one million times less than the ideal value
(-1.1 X 109), the critical a value is derived as 4700 from
Eq. 6. This threshold value is still substantial.
Our CD titration conditions have DNA concentration at
-8 ,uM (a ligand is assumed to occupy a 5-base-pair site),
whereas the fluorescence experiments have it at 0.1 ,LM.
Assuming 1B is optimized to the ideal value, critical a values
4.2 X 105 and 4.7 X 104 can be derived, respectively. If A3
is one million times less than the ideal value, critical a values
as low as 4.2 X 102 and 4.7 X 10 can be derived, respectively.
Clearly, highly sensitive techniques enhance the possibility
of detecting the closed 1:1 DL complex. Other important
factors, unique to CD and fluorometry experimental condi-
tions, also facilitate the observation of the 1:1 DL complex,
which are described further in the following "Reevaluation
of CD and Ethidium Fluorometry" section.
If the 1:1 bidentate binding is not available at all (i.e.,
a = 0), the above analysis indicates the extremely favorable
formation of a 2:2 symmetric complex. We may also gain
some insights into this problem in a different way. The bind-
ing isotherm equation can be simplified as:
k11[L] + 2kllk2l[L]2 + k11K14L][D] + 2kllk22K,2jL]2[D]
y 1 + kj1[L] + k1jk2j[L]2 + 2k1jK12[L][D] + 2klIk2jK22A[L][D]
Previous NMR titration experiment showed that DL2 is the
only species observed when L is a monodentate ligand con-
taining an imidazole or pyridine heterocycle (Dwyer et al.,
1992; Mrksich et al., 1992). Pyrrolecarboxamide lexitropsins
also interact cooperatively with alternating AT sequences in
the 2:1 WPPW mode (Chen and Lown, 1994).
Therefore, kil << k211kjj[L] << 2kllk2l[L]2, k1Kl2[L][D]
<< 2k11k2l[L]2. We may simply compare the 2kllk2,[L] and
2kllk2lK22A[L]2[D] to understand the binding equilibrium,
especially the tendency to form the symmetric 2:2
complex.
2kllk2l[L]2 Vs 2kllk2lK22A[L]2[D] is equivalent to 1 Vs K22A-
[D]. Thus, it follows that the relative magnitude of [D] and
1/K22A will decide the position of the binding equilibrium.
Because K22A may reach an ideal value of 55.6 k1 X k2
under optimized conditions (-10"5), the concentration of
the free DNA can easily exceed the reciprocal of K22A. For
example, at the halfway point in a titration again, [D] =
[D]total/2. [D] Vs 1/K22A is equivalent to [D]total Vs 2/K22A.
Clearly, the tendency to form the symmetric 2:2 complex
REINTERPRETATION OF NMR TITRATION AND
QUANTITATIVE FOOTPRINTING EXPERIMENTS
Upon close inspection, one may notice that those structures
characterized by Dwyer et al. (1993) under NMR titration
conditions cannot account for the small enhancement of ap-
parent binding constants from the quantitative footprinting
measurements. If those structures, so close to the "strainless"
ideal geometry of the unconnected WPPW motif, were true
representations of the bidentate binding motif, binding con-
stants would approximate the theoretical value, 55.6 k, X k2.
The binding enhancement would be very large, not a factor
of 10.
Moreover, the best-fit binding equation for a true bidentate
binding should be first order with respect to the concentration
of any free dimeric ligand, not second order as actually ob-
tained (Mrksich and Dervan, 1993b). The second order equa-
tion can only be interpreted as the domination of 2:1 stoi-
chiometry under the footprinting conditions, as these authors
also indicated. The dominance of 2:1 stoichiometry is not by
accident. Imidazole- or pyridine-containing lexitropsin
monomers have been observed to interact highly coopera-
tively in the 2:1 WPPW mode (Dwyer et al., 1992; Mrksich
et al., 1992). The corresponding term in the binding isotherm
equation is 2K11 X K21[L]2 = 2k1j X k2l[L]2*2k1j X k2l and,
therefore, 2K11 X K21 are relatively unchanged if the ap-
pendage effect on the 1:1 WPW and 2:1 WPPW binding
modes is small and similar. Clearly, the insignificance of the
bidentate binding, i.e., the small a value and, thus, small
contribution from the K11[L] = (1 + a)k1l term, for the pen-
takis(methylene) and hexakis(methylene) linked dimers 3c
and 3d and its total absence for the tris(methylene) and tet-
rakis(methylene) linked dimers 3a and 3b (i.e., a = 0 and
Kll[L] = (1 + a)K11), as supported by our experiments (Chen
and Lown, 1994), results in the dominance of the 2:1 WPPW
term and, therefore, the second order fitting equation ex-
perimentally obtained from quantitative footprinting. The
highly cooperative 2:1 WPPW interaction in effect obscures
the experimentally observable signal from the 1:1 bidentate
interaction completely. As a result, the apparent binding con-
stants, obtained as the square root of the coefficients of the
[L]2 term, are approximately the square root of 2Kj1 X K21
and should be relatively unchanged. Not surprisingly, the
apparent binding constants obtained as such are not related
to the bidentate-binding mode.
The dominance of the 2:1 WPPW binding mode for
these imidazole-containing dimeric lexitropsins under
quantitative footprinting conditions logically leads to fur-
ther aggregation under NMR titration conditions where,
as we know, concentrations are much higher. Therefore,
we can conclude that the covalently connected WPPW
motif characterized by the NMR techniques are actually
the unconnected WPPW motif in symmetric cyclic n:n
complexes instead of the true WPPW 1:1 bidentate-
binding motif (Dwyer et al., 1993). We suggest further
that these symmetric complexes are likely of 2:2 stoi-
is very high under normal NMR titration conditions.
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symmetric polymers are more rigid geometrically and, ac-
cordingly, less capable of escaping from charge repulsion of
outer phosphate groups. Therefore, the stoichiometry factor
would strongly favor formation of the lower aggregation
state, the symmetric 2:2 complex. These considerations may
be substantiated in detail by undertaking a binding equilib-
rium analysis again. Fig. 6 shows the inclusion of a sym-
metric 3:3 closed complex in a binding model.
The binding isotherm equation is as follows:
= (K1I[L] + 2K1K2,[L]2 + K11K12[L][D]
+ 2KllK2lK22A[L]2[D] + 3K11K21K22AK32[L]3[D]
+ 2KllK2lK22AK23[L]2[D]2,
+ 3K11K21K22AK32K33C[L]3[D]2)/(l + K1I[L]
+ K11K21[L]2 + 2K11K12[L][D]
+ 2KllK2lK22A[L]2[D] + 2K11K21K22AK32[L]3[D]
+ 3KllK2lK22AK23[L]2[D]2,
+ 3KllK2lK22AK32K33C[L]3[D]2).
To understand the competition between the symmetric
2:2 and 3:3 closed complexes, we only need to compare
the corresponding terms 2KllK2lK22A[L] [D] and
3KllK2lK22AK32K33A[L]3[D]2 in the numerator of the bind-
ing isotherm equation. Following the similar procedure
used earlier, we can derive Eq. 8:
[D]totW Vs 8NX (1 + 1)3/982k2 (8)
where [D]total > 8N X (3 + 1)3/982k2 if the symmetric 3:3
complex is dominant; [D]totai < 8N X (1 + 1)3/982k2 if the
symmetric 2:2 complex is major. Here N = [D]total/[L]totai,
the same as previously defined. Because of geometric
rigidity and consequent charge repulsion for the sym-
metric 3:3 complex, 1 is likely to be larger than 8. As-
suming N = 2, which represents the halfway point of a
titration, k2 = 20 X 106 M1 and [D]total = 1 mM, typical
of a NMR titration concentration, 13 should be around 104
to allow the symmetric 2:2 complex to predominate ac-
cording to Eq. 8. If one imagines DL2 species of tris-
(methylene) to hexakis(methylene)-linked dimeric lex-
itropsins as "bidentate ligands," the effective cross-linker
_ D2L2
>SK ,-DNA
4DNA"' I'
D3L2
D3L3
FIGURE 6 A binding model that includes a symmetric 3:3 complex. See
Fig. 5 for the early portion of the complete binding equilibrium.
length for such "bidentate ligands" at least equals that of
two tris(methylene) chains, plus the distance between
N-methyl groups of two central pyrrole rings in a 2:1
WPPW antiparallel side-by-side binding motif. This ef-
fective length should be similar to that of the octakis-
(methylene) chain (Chen and Lown, 1994). Our recent
cross-linkage optimization studies suggest that dimeric
lexitropsins with cross-linkers of the approximate length
of the octakis(methylene) chain can achieve a binding
constant enhancement over 104 (Y.-H. Chen and J. W.
Lown, unpublished data). Therefore, it is not unreason-
able to assume that the binding constant enhancement 1
is around 104, and the symmetric 2:2 complex should
prevail over the symmetric 3:3 complex.
In short, under NMR titration conditions, the bidentate
binding is not strong enough to overcome the cooperativity
factor, because of the shortness of the cross-linker. The ini-
tially formed 2:1 dimeric lexitropsin-oligonucleotide com-
plex renders the effective linkage of two unbound moieties
much longer, leading to a genuine bidentate binding to a
second oligonucleotide. The experimental proof of such a
complex may come from molecular weight determination
such as gel permeation chromatography, light scattering, and
ultracentrifugation, or by fitting the dilution curve numeri-
cally using a sensitive monitoring parameter. By including
consideration of other possible structures accounting for
NMR spectra, correcting the interpretation of quantitative
footprinting experiments and, thus, establishing the consis-
tency between NMR and quantitative footprinting data, we
can resolve all apparent differences between two indepen-
dent sets of conclusions.
REEVALUATION OF CD AND ETHIDIUM
FLUOROMETRY EXPERIMENTS
In light of the facile formation of higher aggregates, we have
to reexamine our CD and fluorometry experiments. We have
excluded the possibility of complexation between a dimeric
lexitropsin ligand and two polymeric DNA duplexes, by
analogy with the behavior of dimeric intercalators (Chen and
Lown, 1994). Reexamination of previous experimental data
shows that the polymeric aggregation effect does not inter-
fere in our CD and fluorescence experiments. For example,
the tetrakis(methylene) chain-connected dimer 4a should be
the most likely candidate for cross-complexation because the
short linker disfavors the bidentate binding and provides an
opportunity for cross-complexation without competition.
Its alternating AT polymer titration curve is remarkably simi-
lar to that of the monomer, indicating no sign of cross-
complexation.
Two factors may account for this lack of observable cross-
complexation. First, CD and fluorescence experiments are
carried out under much lower concentrations in terms of ac-
tual binding sites in comparison with the NMR titration,
which shifts the binding equilibrium into the low aggregation
state. Second, the DNAs used in CD and fluorescence ex-
periments are much longer and contain many identical bind-
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ing sites, in contrast to single-sited DNAs in the NMR ti-
tration experiments. This has a series of consequences. There
is a rather strict distance constraint for paired sites suitable
for cross-complexation, which renders the majority of sites
available only for other binding modes without such a con-
straint, even if two polymers are perfectly aligned. If a cross-
complexation takes place at one site, two connected poly-
mers would adopt a crossover orientation rather than a
parallel one to avoid charge repulsion between outer phos-
phate groups. This crossover orientation should reduce the
chance of further cross-complexation. Even if the parallel
orientation is adopted because of another cross-
complexation, the imperfect match of two polymers would
also reduce the possibility of cross-complexation simply be-
cause of statistical reasons.
It is evident that both CD titration curves and ethidium
fluorometry with the alternating AT DNA polymer are very
responsive to the linker change and relatively free of the
aggregation complication. This responsiveness also stems
from the weak binding cooperativity to the polymer by tri-
carboxamide lexitropsins in the 2:1 WPPW mode, as dem-
onstrated fromNMR studies (Fagan and Wemmer, 1992) and
from intrinsic binding constant measurements (Chen and
Lown, 1994). This weak cooperativity facilitates the mani-
festation of both 1:1 WPW and bidentate-binding modes un-
der both sets of experimental conditions.
A corollary of the above analysis is that the cross-
complexation oftwo single-sited DNA duplexes by a dimeric
lexitropsin with a linker ranging from tris(methylene) to hep-
takis(methylene) is highly favored under NMR titration con-
ditions, if only the WPW mode is available for the binding
interaction. In contrast, our recent CD titration experiments
showed no sign of cross-complexation essentially when the
homo AT DNA polymer was used, which allows only the
WPW mode for binding interaction (Y.-H. Chen and J. W.
Lown, unpublished data). Thus, the application of the homo
AT polymer for CD experiments is free of aggregation com-
plication.
In summary, using weakly cooperative lexitropsin-DNA
interacting systems and experimental conditions close to
those of CD and fluorometry experiments has a decisive ad-
vantage over highly cooperative interacting systems and ex-
perimental conditions requiring higher concentrations and
single-sited oligonucleotides as in the NMR studies.
THE SIGNIFICANCE OF 2:2
OLIGONUCLEOTIDE-PEPTIDE COMPLEXES AND
A CAUTIONARY NOTE ABOUT BIOPHYSICAL
AND BIOCHEMICAL CHARACTERIZATION
OF DESIGNED SYSTEMS
The formation of dimeric ligand-oligonucleotide 2:2 com-
plexes is interesting in its own right, and this may actually
represent, to our knowledge, the first example. The crossover
of two DNA molecules mediated by peptides is structurally
reminiscent of some DNA recombination intermediates,
dimensionally nonrandom search for a specific site on a large
DNA molecule by a protein. One remarkable feature of these
now inferred 2:2 complexes is that the linkage can be quite
short. How do DNA duplexes position relative to each other?
A parallel orientation would introduce some charge repulsion
when the linkage is relatively short and therefore a perpen-
dicular orientation should be preferred in such a case. There
are some other interesting questions to be answered. Perhaps
the further cross-linkage of these dimeric ligands provides a
novel class of tetrameric lexitropsins with very strong cross-
complexation ability, which serve as useful structural probes
of DNA as well as simple models of DNA crossover struc-
tures. There was no significant 2:2 complex formation under
quantitative footprinting conditions where a large DNA frag-
ment and lower concentrations of DNA and ligands were
used, as suggested from the experimentally derived second
order binding equations with correlation coefficients over
97% (Mrksich and Dervan, 1993b). This means that a stron-
ger cross-complexation interaction is required for the for-
mation of a DNA crossover structure under such conditions.
It seems very likely that dimeric intercalators and major
groove binders can be designed and elaborated to cross-
complex with two DNA duplexes.
In summary, sensitive techniques like CD and fluores-
cence have their roles to play in elucidating molecular in-
teractions despite the fact that they are indirect and nonvi-
sual. High dilution conditions eliminate some structural
"artifacts" that would not appear under biological conditions.
After all, in vivo processes often take place under relatively
low concentration conditions. A powerful technique like
NMR spectroscopy has its limitations in distinguishing sym-
metric structures, and the insensitivity of this technique will
continue to affect binding studies wherever equilibria exist.
Therefore, the combination with other sensitive hydrody-
namic and spectroscopic techniques is highly desirable in
certain situations. Structural studies should become more
meaningful when correlated with careful thermodynamic
analysis. The apparent binding constant formalism should be
treated with due caution because the constant might be a sort
of averaging over intrinsic binding constants, and this av-
erage value is meaningless if one is not aware of the pos-
sibility of mutual cancellation of the intrinsic binding con-
stants in certain situations. This cautionary note also
demonstrates a possibly general situation in molecular en-
gineering where the molecular system has to be optimized to
a high threshold point observe the intended function with
some conventional techniques, even though the design fea-
ture is essentially correct. Therefore, investigation of mar-
ginally optimized systems, although informative, can be
challenging, and one should proceed with caution.
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